Komori
Alfresa Holdings (2784) · FactAdvanced

Four-segment structure covering wholesaling, manufacturing and dispensing pharmacies

First written in FY2016. 23 of 26 entries say "Restated". Latest entry: FY2026-H1.

26entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2025-H12016: 220162017: 320172018: 320182019: 420192020: 320202021: 420212022: 320222023: 120232024: 120242025: 22025
Same theme, other companies

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026-H1AdvancedAnnual report

    「From the current interim consolidated accounting period, the Company has renamed the former healthcare-related business as the dispensing pharmacy and other business.」

    From the fiscal year ending March 2026, the former healthcare-related business was renamed the dispensing pharmacy and other business, and an Other category including the regenerative medicine-related business was newly established. The reporting structure has in fact changed from four segments to a structure adding Other.
  2. FY2025ReframedAnnual report

    「From the beginning of the fiscal year ending March 2026, the former healthcare-related business was renamed the “Prescription Pharmacies and Other Business,” and a new Other business segment was established.」

    While maintaining the current four reportable segments, the Company plans to rename the healthcare-related business as the dispensing pharmacy and other business from the fiscal year ending March 2026 and establish a new Other business segment.
  3. FY2025-H1RestatedAnnual report

    「During the interim consolidated accounting period, there were no material changes to the business activities conducted by the Group (the Company and its affiliated companies). There were also no changes among its principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  4. FY2024-Q2RestatedAnnual report

    「During the first half of the current consolidated fiscal year, there were no material changes to the businesses conducted by the Group (the Company and its affiliated companies). There were also no changes in the principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  5. FY2023-Q2RestatedAnnual report

    「During the first half of the current consolidated fiscal year, there were no material changes to the businesses conducted by the Group (the Company and its affiliated companies). There were also no changes in the principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  6. FY2023-Q1RestatedAnnual report

    「During the first quarter of the current consolidated fiscal year, there were no material changes to the businesses conducted by the Group (the Company and its affiliated companies). There were also no changes in the principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  7. FY2022-Q3RestatedAnnual report

    「During the first nine months of the current fiscal year, there were no material changes to the business activities conducted by the Group (the Company and its affiliated companies). There were also no changes among its principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  8. FY2022-Q2RestatedAnnual report

    「During the first half of the current consolidated fiscal year, there were no material changes to the businesses conducted by the Group (the Company and its affiliated companies). There were also no changes in the principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  9. FY2022-Q1RestatedAnnual report

    「During the first quarter of the current consolidated fiscal year, there were no material changes to the businesses conducted by the Group (the Company and its affiliated companies). There were also no changes in the principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  10. FY2021RestatedAnnual report

    「The Company has four reportable segments: the wholesale business for prescription pharmaceuticals and other products, the self-medication wholesale business, the manufacturing business for pharmaceuticals and other products, and the healthcare-related business.」

    The Company continues to operate under a four-segment structure comprising prescription pharmaceutical wholesaling, self-medication wholesaling, manufacturing and healthcare-related businesses.
  11. FY2021-Q3RestatedAnnual report

    「During the first nine months of the current fiscal year, there were no material changes to the business activities conducted by the Group (the Company and its affiliated companies). There were also no changes among its principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  12. FY2021-Q2RestatedAnnual report

    「During the first half of the current consolidated fiscal year, there were no material changes to the businesses conducted by the Group (the Company and its affiliated companies). There were also no changes in the principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  13. FY2021-Q1RestatedAnnual report

    「During the first quarter of the current consolidated fiscal year, there were no material changes to the businesses conducted by the Group (the Company and its affiliated companies). There were also no changes in the principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  14. FY2020-Q3RestatedAnnual report

    「During the first nine months of the current fiscal year, there were no material changes to the business activities conducted by the Group (the Company and its affiliated companies). There were also no changes among its principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  15. FY2020-Q2RestatedAnnual report

    「During the first half of the current consolidated fiscal year, there were no material changes to the businesses conducted by the Group (the Company and its affiliated companies). There were also no changes in the principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  16. FY2020-Q1RestatedAnnual report

    「During the first quarter of the current consolidated fiscal year, there were no material changes to the businesses conducted by the Group (the Company and its affiliated companies). There were also no changes in the principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  17. FY2019RestatedAnnual report

    「The Company has four reportable segments: the wholesale business for prescription pharmaceuticals and other products, the self-medication wholesale business, the manufacturing business for pharmaceuticals and other products, and the healthcare-related business.」

    There have been no material changes to the four-business-segment structure.
  18. FY2019-Q3RestatedAnnual report

    「During the first nine months of the current fiscal year, there were no material changes to the business activities conducted by the Group (the Company and its affiliated companies). There were also no changes among its principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  19. FY2019-Q2RestatedAnnual report

    「During the first half of the current consolidated fiscal year, there were no material changes to the businesses conducted by the Group (the Company and its affiliated companies). There were also no changes in the principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  20. FY2019-Q1RestatedAnnual report

    「During the first quarter of the current consolidated fiscal year, there were no material changes to the businesses conducted by the Group (the Company and its affiliated companies). There were also no changes in the principal affiliated companies.」

    The Company states that there have been no material changes to its business activities, including the four business segments, or to its principal affiliated companies.
  21. FY2018-Q3RestatedAnnual report

    「There have been no material changes to the nature of the businesses operated by our Group, comprising our company and its affiliated companies, during the nine-month period ended 31 December.」

    The Company states that there have been no material changes to its business activities, including the four reportable segments.
  22. FY2018-Q2RestatedAnnual report

    「There have been no material changes to the nature of the businesses operated by our Group, comprising our company and its affiliated companies, during the six-month period ended 30 September.」

    The Company states that there have been no material changes to its business activities, including the four reportable segments.
  23. FY2018-Q1RestatedAnnual report

    「During the first quarter of the current consolidated fiscal year, there were no material changes in the businesses operated by our group (the company and its affiliated companies).」

    The Company states that there have been no material changes to its business activities, including the four reportable segments.
  24. FY2017-Q3RestatedAnnual report

    「There have been no material changes to the nature of the businesses operated by our Group, comprising our company and its affiliated companies, during the nine-month period ended 31 December.」

    The Company states that there have been no material changes to its business activities, including the four reportable segments.
  25. FY2017-Q1RestatedAnnual report

    「During the first quarter of the current consolidated fiscal year, there were no material changes in the businesses operated by our group (the company and its affiliated companies).」

    The Company states that there have been no material changes to its business activities, including the four reportable segments.
  26. FY2016First statedAnnual report

    「The Company has four reportable segments: the wholesale business for prescription pharmaceuticals and other products, the self-medication wholesale business, the manufacturing business for pharmaceuticals and other products, and the healthcare-related business.」

    The Company has four segments, centered on prescription pharmaceutical wholesaling and including self-medication, manufacturing and dispensing pharmacies.
Moved together

"Recognition of Impairment Losses on Fixed Assets" moved the same way as this thread, in the same document, in 2 of its 26 moves.

22★12
  1. ★This thread
  2. 1Recognition of Impairment Losses on Fixed Assets2×
  3. 2Investment of approximately ¥120 billion over 3 years2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Four-segment structure covering wholesaling, manufacturing and dispensing pharmacies | Alfresa Holdings Corporation (2784) | Komori